The association between circulating retinol-binding protein 4 (RBP4) and risk of type 2 diabetes has been inconsistent in cross-sectional studies, but prospective evidence is limited. We aimed to investigate whether plasma RBP4 is associated with future development of type 2 diabetes and whether the association could be explained by iron or other risk factors. A total of 2091 Chinese adults aged 50-70 y were followed up for 6 y. Baseline dietary intakes and fasting plasma RBP4, ferritin, adiponectin, C-reactive protein (CRP), g-glutamyltransferase, creatinine, and erythrocyte fatty acids were determined. Self-reported doctor-diagnosed diabetes, or usage of antidiabetic agents, or fasting plasma glucose concentration at the follow-up visit $7.0 mmol/L was defined as an incident diabetes case. Plasma RBP4 concentration was significantly associated with dietary heme iron intake, plasma ferritin concentration, and other established risk factors.
Introduction
The global epidemic of type 2 diabetes has become a major public health concern with serious social and economic consequences. In China, >90 million adults were estimated to have diabetes, with the majority of the cases undiagnosed (1) . Although major driving factors behind the epidemic are poor nutrition and lifestyle transitions (2) , growing evidence supports a role of multiple adipokines in the pathogenesis of type 2 diabetes (3, 4) .
Retinol-binding protein 4 (RBP4) 10 was originally considered to be a retinol transport protein synthesized mainly by the liver (5) until its expression in adipocytes was first discovered in 1992 (6) . More recently, RBP4 has been recognized as a novel adipokine that is elevated in the mouse model of insulin resistance, as well as in patients with obesity and/or type 2 diabetes (7, 8) . The injection of purified RBP4 into mice was shown to induce hepatic expression of phosphoenolpyruvate kinase in addition to impaired muscle insulin signaling (7) , indicating the potential role of RBP4 in the development of type 2 diabetes. Our previous cross-sectional analyses also showed that increased RBP4 was independently associated with metabolic syndrome, a well-established precursor to type 2 diabetes (9) . Moreover, a nested case-control study reported a time-dependent association between higher circulating RBP4 and elevated risk of coronary heart disease (10) . However, available cross-sectional studies show inconsistent results on the RBP4-diabetes association (8, (11) (12) (13) (14) (15) (16) , although prospective evidence is limited.
The potential pathways underlying the association between RBP4 and metabolic disorders are not well understood. Given that vitamin A and iron interact in multiple physiologic processes and that the concentrations of RBP4 and ferritin changed simultaneously in human studies, Fernández-Real et al. (17) hypothesized that the association between RBP4 and insulin resistance might be explained by iron overload to some extent. However, whether iron overload could contribute to the RBP4-diabetes association has not been evaluated previously.
Therefore, in an established 6-y cohort of middle-aged and elderly Chinese adults, our study aimed to explore the following: 1) the relation between iron (dietary intake and/or body stores) and plasma RBP4 concentration; 2) the association between elevated plasma RBP4 and risk of developing type 2 diabetes; and 3) whether the RBP4-diabetes association could be explained by iron (dietary intake and/or body stores) and other established risk factors, such as obesity, inflammatory markers, adipokine, liver and kidney function, hypertension, and insulin resistance.
Materials and Methods
Participants. The Nutrition and Health of Aging Population in China study, conducted using noninstitutionalized residents aged 50-70 y from Beijing and Shanghai, was designed to prospectively investigate the roles of genetic and environmental risk factors and their interactions in the occurrence and development of metabolic disorders (18) . The Institutional Review Board of the Institute for Nutritional Sciences approved the study protocol. All participants provided written informed consents.
In 2005, we conducted the baseline survey and successfully enrolled 3289 residents (18) . Information on demographic and lifestyle factors, family history of diabetes, and dietary intakes were collected using standardized questionnaires (18, 19) . Anthropometric data of weight, height, waist and hip circumference, and blood pressure were obtained by physical examinations following standardized procedures (18) . The food-composition values were derived from the Chinese Food Composition Table, in which retinol and carotenoids were counted for total vitamin A (20) . The residual model was used to calculate the energyadjusted nutrient intakes (21) .
In 2011, all participants were contacted for the 6-y follow-up survey. The same set of questionnaires and anthropometric protocols used at baseline were applied with minor modifications to collect follow-up data. Details of the follow-up survey have been described previously (22) . In brief, there were 760 (23.1%) participants lost to follow-up because of loss of contact (n = 554, 16.8%) or refusal to participate in the follow-up survey (n = 206, 6.3%). Therefore, a total of 2529 eligible individuals were enrolled. Among them, we further excluded 331 individuals with diabetes at baseline and 107 individuals with extreme intake of total energy (for men, <800 or >4000 kcal/d; for women, <500 or >3500 kcal/d). Thus, the current analysis consisted of 2091 participants.
Laboratory measurements. Peripheral venous blood samples were collected after overnight fasting. Plasma RBP4 was measured by in-house developed sandwich ELISA in duplicate (9) . The intra-assay and interassay CVs were 1.8-7.6% and 3.7-8.8%, respectively. The measurements of plasma glucose, lipids, g-glutamyltransferase (GGT), insulin, adiponectin, C-reactive protein (CRP), ferritin, and erythrocyte glycohemoglobin and FAs have been described previously (18, 19, 22) . Plasma creatinine was measured using a Hitachi 7080 automatic analyzer with commercial reagents (Wako Pure Chemical Industries). The equation of insulin (mU/mL) 3 glucose (mmol/L)/22.5 was used to calculate the HOMA-IR.
Type 2 diabetes definition. Incident diabetes cases during 6-y followup were defined by the following methods: 1) self-reported doctordiagnosed diabetes or use of antidiabetic agents; or 2) fasting plasma glucose concentration at the follow-up visit $7.0 mmol/L. Statistical analysis. Values in the text are means 6 SDs or RRs (95% CIs). Covariate distributions between incident diabetes cases and noncases were compared using ANCOVA for continuous variables and x 2 test for categorical variables in eligible participants. ANCOVA was used to compare plasma RBP4 concentrations across the quartiles of ferritin and dietary intake of heme iron, total iron, retinol, total vitamin A, and red and processed meat, respectively. Spearman correlation analysis was used to calculate the correlation coefficients between plasma RBP4 and baseline metabolic parameters. TGs, insulin, HOMA-IR, adiponectin, CRP, GGT, and ferritin were log-transformed to approximate normality. Person-years of type 2 diabetes were unable to be accurately estimated because most cases were defined in the follow-up survey. Instead, RRs of type 2 diabetes according to RBP4 quartiles were calculated in sequential logistic regression models after adjustment for confounding factors: 1) model 1: sex, age (continuous), region (Beijing/ Shanghai), residence (urban/rural), education amount (year), current smoking and drinking status (yes/no), physical activity amounts, and family history of diabetes (yes/no); 2) model 2: BMI (continuous); 3) model 3: plasma adiponectin, CRP, TGs, HDL cholesterol, GGT, creatinine, HOMA-IR, and hypertension; and 4) model 4: ferritin, de novo lipogenesis (DNL) FAs (16:0 and 16:1n-7), and intakes of total energy, fat, heme iron, and retinol. Because of the high cumulative diabetes incidence (24.2%, 507 of 2091) in the current study, log-Poisson models were applied to estimate the RRs and CIs as a sensitivity analysis (23) . Furthermore, restricted quadratic splines with 3 knots (5th, 50th, and 95th percentiles) were applied to model the dose-response relation between RBP4 (as continuous variables) and RRs of type 2 diabetes. Joint classification analyses were also conducted to examine whether obesity, HOMA-IR, GGT, ferritin, and DNL FAs (16:0 and 16:1n-7) could modify the RBP4-diabetes association. The likelihood ratio tests were used to assess interactions. All statistical analyses were performed with SAS version 9.3 (SAS Institute). Two-sided P < 0.05 was considered as statistically significant.
Results
Baseline characteristics. Comparisons of baseline characteristics between incident diabetes cases and noncases are shown in Table 1 . Compared with noncases, diabetes cases were more likely to include participants who were from Beijing and had a family history of diabetes. With respect to the baseline metabolic parameters, diabetes cases also exhibited higher amounts of BMI, waist circumference, blood pressure, TGs, glucose, glycohemoglobin, insulin, HOMA-IR, CRP, GGT, ferritin, and DNL FAs 16:0, 16:1n-9, and 16:1n-7, as well as lower HDL cholesterol and adiponectin concentrations than noncases (all P < 0.05). Baseline plasma RBP4 concentrations were significantly higher in incident diabetes cases than noncases (mean 6 SD: 41.4 6 12.9 vs. 38.6 6 11.0 mg/mL; P < 0.001). However, no difference was observed for dietary intake of retinol or total vitamin A.
Plasma RBP4 was positively correlated with BMI, waist circumference, blood pressure, total and LDL cholesterol, TGs, glycohemoglobin, insulin, HOMA-IR, GGT, creatinine, ferritin, and erythrocyte FAs 14:0, 16:1n-9, 16:1n-7, and 18:1n-9 but inversely correlated with HDL cholesterol, adiponectin, and erythrocyte FAs 18:0 and 18:1n-7 (all P < 0.01; Table 2 ), after controlling for sex, age, region, and residence.
Association between RBP4 and dietary factors. Dietary heme iron, retinol, and red and processed meat were positively associated with plasma RBP4 concentrations, after adjusting for sex, age, region, and residence. As shown in Figure 1 , RBP4 4 Data are missing for 57 participants. 5 Data are missing for 9 participants. 6 Data are missing for 25 participants.
concentrations increased across the quartiles of ferritin (P < 0.001) and dietary intake of heme iron (P < 0.001), retinol (P = 0.002), and red and processed meat (P = 0.042).
Association between RBP4 and incidence of type 2 diabetes. Of the 2091 participants included in the current analysis, we documented 507 (24.2%) incident diabetes cases during the 6-y follow-up. The risk of developing type 2 diabetes was greater in the highest RBP4 quartile compared with the lowest quartile (RR = 1.75; 95% CI: 1.30, 2.37; P-trend < 0.001), after adjusting for demographic and lifestyle factors and family history of diabetes (model 1) ( Table 3) . The association was attenuated slightly when BMI was included in the model (RR = 1.55; 95% CI: 1.14, 2.10; P-trend = 0.009) (model 2). Replacing BMI with waist circumference as a covariate in the model resulted in little change in the magnitude of association (RR = 1.47; 95% CI: 1.08, 2.00; P-trend = 0.024). The RBP4-diabetes association was not altered when further controlling for plasma adiponectin, CRP, and other relevant risk factors, including TGs, HDL cholesterol, GGT, creatinine, HOMA-IR, and hypertension (model 3). Further controlling for ferritin, DNL FAs, and intakes of total energy, fat, heme iron, and retinol did not change the RBP4-diabetes association (model 4). In sensitivity analysis of log-Poisson models, the magnitude of the RBP4-diabetes association was slightly reduced but remained statistically significant (RR = 1.32; 95% CI: 1.05, 1.66; P-trend = 0.034) (model 4). There was a clear threshold effect in that the RR of type 2 diabetes did not start to increase until RBP4 concentrations exceeded ;50 nmol/L ( Fig. 2 , P = 0.026 for nonlinearity). In fact, a total of 332 participants in the current study exhibited an RBP4 concentration >50 nmol/L, and all of them belonged to the highest RBP4 quartile.
When joint classification analyses were further conducted to examine whether obesity, HOMA-IR, GGT, ferritin, and DNL FAs could modify the RBP4-diabetes association (Supplemental Fig. 1) , none of the interactions were statistically significant (all P-interaction > 0.05).
Discussion
In this 6-y cohort of middle-aged and elderly Chinese adults, we observed a significant association between higher plasma RBP4 concentrations and increased risk of developing type 2 diabetes in both men and women, after controlling for demographic and lifestyle factors, family history of diabetes, ferritin, dietary 3 Data are missing for 57 participants. 4 Data are missing for 9 participants. 5 Data are missing for 25 participants. factors, and other risk factors, including obesity, adiponectin, CRP, lipids, liver and kidney function, insulin resistance, and hypertension. Our study indicated that higher plasma RBP4 concentrations were independently associated with incident diabetes in Chinese men and women. RBP4 has been known as the retinol carrier in blood since the 1960s (24) . Its emerging role as an ''adipocyte-derived signal'' of type 2 diabetes was first revealed by the work of Yang et al. in 2005 (7) . Their animal model experiments suggested a close relation between RBP4 and systemic insulin resistance. However, Mercader et al. (25) showed that RBP4 concentration decreased in insulin-resistant fa/fa Zucker rats or remained unchanged in diet-induced obese rats when compared with lean controls. Meanwhile, the relation between RBP4 and type 2 diabetes remains controversial in human studies (8, (11) (12) (13) (14) (15) (16) . Results from previous studies were basically cross-sectional in nature and had relatively small sample sizes. For instance, Graham et al. (8) found that circulating RBP4 was higher in 40 individuals with type 2 diabetes or impaired glucose tolerance than in 20 controls of normal glucose tolerance, whereas Erikstrup et al. (11) observed that RBP4 concentration was lower in patients with diabetes compared with those with normal glucose tolerance. More recently, Meisinger et al. (26) reported an independent association between RBP4 and prevalence of prediabetes in the Cooperative Health Research in the Region of Augsburg (KORA) F4 Study . In a Korean cohort of 479 individuals without diabetes, Rhee et al. (27) did not document significant differences when comparing baseline RBP4 concentrations among 3 groups with different glycemic changes (maintenance, progression, or regression) after a 4-y follow-up. The discrepancies among different studies could be ascribed to insufficient sample size, variations in study design, or characteristics of study populations. Notably, although ELISA methods have been used in most of the existing studies (8, (11) (12) (13) 15, 16, 27) , the influence of interlaboratory variations on the methodology cannot be completely ruled out (28) . Thus, it may not be appropriate to simply compare the absolute value of circulating RBP4 from 1 study to another. In the current study, we observed a prospective association of increased baseline RBP4 concentrations with elevated 6-y risk of developing diabetes in both men and women, independent of established risk factors. Interestingly, our analysis indicated a threshold effect in which RBP4 might contribute to increased diabetes risk only in the highest quartile.
Previous evidence suggested an interaction between vitamin A and iron in physiologic processes. For instance, vitamin A supplementation showed a beneficial effect on iron status and metabolism (29, 30) , and the deficiency of iron and vitamin A often coexist (31) . Conversely, taking iron supplementation in preschoolers (32) or depleting iron as a therapy in patients with type 2 diabetes (17) could also change RBP4 concentrations. Meanwhile, the iron donor lactoferrin increased RBP4 expression and release in adipose tissue (17) . Together, the available evidence suggested the potential role of iron in regulating RBP4 concentrations. Because of the recognized effect of excessive iron load on metabolic disorders, Fernández-Real et al. (17) suggested that iron might also contribute to the association between RBP4 and insulin resistance. In the current study, the positive association between dietary heme iron and plasma RBP4 concentrations presumably would enhance the close relation between iron and vitamin A metabolism. However, there was no significant association found between heme iron intake and incident diabetes, which might be due to the relatively lower overall intake of heme iron in our population compared with those in Western populations (33) . As an alternative, a positive association between elevated body iron stores, represented by higher plasma ferritin concentrations, and increased incidence of type 2 diabetes was evidenced previously in the same study population (34) . Nevertheless, the strength of the correlation between ferritin and RBP4 in our study was not as strong as those in the study by Fernández-Real et al. (correlation coefficient = 0.13 vs. 0.35-0.61), and adjusting for ferritin in statistical models did not attenuate the RBP4-diabetes association. FIGURE 2 Dose-response relation between plasma RBP4 concentration and RR of type 2 diabetes in middle-aged and elderly Chinese adults; n = 2091. RRs were estimated using a logistic regression model after adjustment for sex, age, region, residence, education, current smoking and drinking status, physical activity, family history of diabetes, and BMI; P = 0.026 for nonlinearity. RBP4, retinol-binding protein 4.
Liver is the known major organ involved in RBP4 synthesis. Heightened circulating RBP4 concentrations were found in patients having nonalcoholic fatty liver disease (35) and were also associated with liver fat deposition in healthy individuals (36) . In the current study, we also found a positive correlation between RBP4 and GGT (r = 0.22, P < 0.001). Because nonalcoholic fatty liver disease and/or raised hepatic enzymes were predictors of type 2 diabetes (37), we examined to what extent that the elevated hepatic enzyme could influence RBP4-diabetes association, but no material change was found when further controlling for GGT. Furthermore, liver is known for playing a crucial role in the DNL process (38) , which also contributes to the formation of hepatic steatosis (39) . Previously, higher DNL FAs 16:0 and 16:1n-7 were observed to be positively associated with increased 6-y risk of type 2 diabetes in this population (22) . However, although RBP4 was correlated with most of DNL FAs in the current study, the RBP4-diabetes association remained unchanged after adding 16:0 and 16:1n-7 FAs in the statistical model.
High circulating RBP4 in our study and others (7-9) has been linked to insulin resistance, which is a major contributor to type 2 diabetes. Although the underlying mechanisms are not well understood, Yang et al. (7) postulated a potential mechanism of RBP4 via inducing hepatic expression of phosphoenolpyruvate kinase and suppressing muscle insulin signaling. Recently, they also put forth another new hypothesis that RBP4 may induce insulin resistance by stimulating inflammatory state in adipose tissue (40) . Meanwhile, other researchers also revealed the underlying role of stimulated by retinoic acid 6, which could activate the Janus kinase/signal transducer and activator of transcription signaling cascade, in the link between RBP4 and insulin resistance (41, 42) . However, the RBP4-diabetes association in our analysis was independent of adiposity and inflammation. In addition, we observed that incidence of type 2 diabetes was elevated in the top category of RBP4 regardless of the amounts of HOMA-IR. Therefore, RBP4 may increase the risk of type 2 diabetes through pathway(s) not largely overlapping with insulin resistance. Certainly, our results should be confirmed in future studies with hyperinsulinemic euglycemic clamp technique or minimal model analysis. Mechanistic evidence regarding how RBP4 facilitates the pathogenesis of type 2 diabetes is needed in additional studies.
The strength of the current study included that plasma RBP4 concentrations were analyzed in duplicate manner to minimize measurement error. Furthermore, comprehensive information on most potential confounders was collected and carefully controlled for in statistical analyses. Admittedly, our study had several limitations. First, only 77% of participants were successfully followed up. However, the follow-up rate was comparable with previous prospective studies conducted in elderly people (43, 44) . Second, our participants are limited to middle-aged and elderly adults, who have higher risk of developing type 2 diabetes than the general population. Therefore, it is not known whether the results could be generalized to other age groups. Last, the observed RBP4-diabetes association does not prove causality, and residual confounding cannot be fully ruled out.
In summary, we found a significant positive association between plasma RBP4 concentrations and risk of developing type 2 diabetes in a Chinese population after 6-y follow-up. Our data suggest that RBP4 is independently associated with future development of type 2 diabetes. Certainly, additional research is needed to confirm our results and elucidate potential biologic mechanisms underlying this association.
